Market Overview:
The urolithiasis management devices market comprises products used for diagnosis and treatment of kidney stones. This includes lithotripsy devices, ureteroscopes, nephroscopes, and stone retrieval devices. Lithotripsy devices have the largest market share as they provide non-invasive treatment for breaking kidney stones into smaller fragments which helps in easier removal.
Market key trends:
One of the key trends in the urolithiasis management devices market is the increasing popularity of minimally invasive surgeries. Minimally invasive surgeries such as ureteroscopy and percutaneous nephrolithotomy offer advantages over conventional open surgeries such as reduced post-operative pain, shorter hospital stay, and faster recovery time. Technological advancements are enabling wider application of minimally invasive surgeries. For instance, digital flexible ureteroscopes provide high definition visualization for efficient stone manipulation and retrieval. Advancements in lithotripsy devices such as compact size, higher efficacy in breaking stones, and versatility for extracorporeal and intracorporeal procedures are encouraging their adoption.
Segment Analysis
The global Urolithiasis Management Devices Market Demand is segmented on the basis of device type, procedure type, end user and geography.By device type, the market is segmented into lithotripsy devices, ureterorenoscopes, nephroscopes and others. Among these, the lithotripsy devices segment dominated the market in 2022 due to high adoption of these devices for minimally invasive stone treatment. Extracorporeal shock wave lithotripsy (ESWL) has high success rate and no incision requirement which makes it most commonly used procedure for stone treatment across the world.
By procedure type, the market is segmented into extracorporeal shock wave lithotripsy, intracorporeal ureterolithotripsy, percutaneous nephrolithotomy and others. The extracorporeal shock wave lithotripsy segment accounted for largest share in 2022 owing to its wide application in treatment of renal stones as well as ureteric stones.
Key Takeaways
The global urolithiasis management devices market is expected to witness high growth, exhibiting CAGR of 4.8% over the forecast period, due to increasing prevalence of kidney stones and technological advancements in stone removal devices.
Regional analysis- North America dominated the global market in 2022 and is expected to maintain its dominance over the forecast period. This is attributed to growing geriatric population, increasing healthcare expenditure and presence of major players in the region. Asia Pacific is expected to exhibit fastest growth during the forecast period driven by rising awareness about stone disease management and improving healthcare infrastructure in emerging countries.
Key players analysis- Key players operating in the urolithiasis management devices market are Lumenis Ltd., Boston Scientific Corp, BD, Cook Medical, Karl Storz, Allengers Medical Systems, Inc, Olympus Corporation, Electro Medical Systems SA, Dornier MedTech GmbH, Direx Group., HealthTronics, Inc., CONMED Corporation., Applaud Medical, Inc., Potent Medical., and other prominent players. These players are focusing on new product launches and geographic expansion to strengthen their market position. For instance, in January 2020, Olympus Corporation launched the Soltive SuperPulsed Laser Lithotripsy System in the US and other markets to treat urinary stones.
Note:
- Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
